Insufficient scRNA-seq data for expression of IL36B at single-cell level.
Insufficient scRNA-seq data for expression of IL36B at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| skin | 69% | 241.25 | 1252 / 1809 | 11% | 0.48 | 52 / 472 |
| esophagus | 24% | 32.28 | 341 / 1445 | 36% | 2.50 | 66 / 183 |
| tonsil | 0% | 0 | 0 / 0 | 31% | 0.75 | 14 / 45 |
| lung | 0% | 0 | 0 / 578 | 12% | 0.54 | 136 / 1155 |
| uterus | 1% | 0.51 | 1 / 170 | 10% | 0.27 | 45 / 459 |
| intestine | 0% | 0 | 0 / 966 | 6% | 1.97 | 29 / 527 |
| bladder | 0% | 0 | 0 / 21 | 5% | 0.19 | 23 / 504 |
| stomach | 0% | 0 | 0 / 359 | 5% | 0.25 | 13 / 286 |
| pancreas | 0% | 0 | 0 / 328 | 4% | 0.20 | 8 / 178 |
| brain | 0% | 0 | 0 / 2642 | 4% | 0.10 | 28 / 705 |
| kidney | 0% | 0 | 0 / 89 | 1% | 0.05 | 12 / 901 |
| adrenal gland | 0% | 0 | 0 / 258 | 1% | 0.01 | 2 / 230 |
| breast | 0% | 0 | 0 / 459 | 1% | 0.02 | 7 / 1118 |
| thymus | 0% | 0 | 0 / 653 | 0% | 0.00 | 2 / 605 |
| adipose | 0% | 0.19 | 3 / 1204 | 0% | 0 | 0 / 0 |
| liver | 0% | 0 | 0 / 226 | 0% | 0.00 | 1 / 406 |
| muscle | 0% | 0.05 | 1 / 803 | 0% | 0 | 0 / 0 |
| blood vessel | 0% | 0.11 | 1 / 1335 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ovary | 0% | 0 | 0 / 180 | 0% | 0 | 0 / 430 |
| peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| prostate | 0% | 0 | 0 / 245 | 0% | 0 | 0 / 502 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0071222 | Biological process | cellular response to lipopolysaccharide |
| GO_0006955 | Biological process | immune response |
| GO_0010628 | Biological process | positive regulation of gene expression |
| GO_0019221 | Biological process | cytokine-mediated signaling pathway |
| GO_0045582 | Biological process | positive regulation of T cell differentiation |
| GO_0002437 | Biological process | inflammatory response to antigenic stimulus |
| GO_0045087 | Biological process | innate immune response |
| GO_0005615 | Cellular component | extracellular space |
| GO_0005576 | Cellular component | extracellular region |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005125 | Molecular function | cytokine activity |
| GO_0005149 | Molecular function | interleukin-1 receptor binding |
| Gene name | IL36B |
| Protein name | Interleukin-36 beta (FIL1 eta) (Interleukin-1 eta) (IL-1 eta) (Interleukin-1 family member 8) (IL-1F8) (Interleukin-1 homolog 2) (IL-1H2) |
| Synonyms | IL1H2 IL1F8 |
| Description | FUNCTION: Cytokine that binds to and signals through the IL1RL2/IL-36R receptor which in turn activates NF-kappa-B and MAPK signaling pathways in target cells linked to a pro-inflammatory response. Part of the IL-36 signaling system that is thought to be present in epithelial barriers and to take part in local inflammatory response; similar to the IL-1 system with which it shares the coreceptor IL1RAP. Stimulates production of interleukin-6 and interleukin-8 in synovial fibrobasts, articular chondrocytes and mature adipocytes. Induces expression of a number of antimicrobial peptides including beta-defensins 4 and 103 as well as a number of matrix metalloproteases. Seems to be involved in skin inflammatory response by acting on keratinocytes, dendritic cells and indirectly on T-cells to drive tissue infiltration, cell maturation and cell proliferation. In cultured keratinocytes induces the expression of macrophage, T-cell, and neutrophil chemokines, such as CCL3, CCL4, CCL5, CCL2, CCL17, CCL22, CL20, CCL5, CCL2, CCL17, CCL22, CXCL8, CCL20 and CXCL1, and the production of pro-inflammatory cytokines such as TNF-alpha, IL-8 and IL-6. . |
| Accessions | Q9NZH7 ENST00000327407.2 [Q9NZH7-2] ENST00000259213.9 [Q9NZH7-1] |